Conformationally Restricted Carbocyclic γ-Amino Acids: Synthesis of Diastereomeric 3-Amino-5-arylcyclopentane 1-Carboxylic Acids

Abstract

A Trost Pd-catalyzed [3+2] cycloaddition between a p-benzyloxy cinnamate bearing an Evans auxiliary and 1-trimethylsilyl-2-acetoxymethylpropene is disclosed leading to, after functional group manipulation, previously unreported diastereoisomeric 3-amino-5-arylcyclopentane 1-carboxylic acids via the corresponding 3-hydroxy and 3-azido precursors. The availability of these conformationally restricted cyclic amino acids may find utility in the context of CNS-active compounds related to GABA, or as peripheral units of bioactive pharmaceuticals. An expedient alternative 4-step synthesis of 3S-amino-5S-p-hydroxyphenyl-1S-cyclopentane carboxylic acid methyl ester was achieved starting with the (–)-Vince lactam and utilizing a regio- and diastereoselective Pd-catalyzed hydroarylation reaction.

Key words

GABA - γ- amino acid - [3+2] cycloaddition - Vince lactam - hydroarylation - conformational restriction

Publikationsverlauf

Eingereicht: 09. Mai 2023

Angenommen nach Revision: 10. Juli 2023

Artikel online veröffentlicht:
04. September 2023

• References

• 1 Han J, Konno H, Sato T, Soloshonok VA, Izawa K. Eur. J. Med. Chem. 2021; 220: 113448
• 2 Yin Z, Hu W, Zhang W, Konno H, Moriwaki H, Izawa K, Han J, Soloshonok VA. Amino Acids 2020; 52: 1227
• 3 Ding Y, Ting JP, Liu J, Al-Azzam S, Pandya P, Afshar S. Amino Acids 2020; 52: 1207
• 4 Blaskovich MA. T. J. Med. Chem. 2016; 59: 10807
• 5 Ordóñez M, Cativiela C. Tetrahedron: Asymmetry 2007; 18: 3
• 6 Froestl W. Future Med. Chem. 2011; 3: 163
• 7 Benzon H, Rathmell JP, Wu CL, Turk DC, Argoff CE, Hurley RW. In Practical Management of Pain . Elsevier Health Sciences; Amsterdam: 2013: 1006
• 8 Liu J, Han J, Izawa K, Sato T, White S, Meanwell NA, Soloshonok VA. Eur. J. Med. Chem. 2020; 208: 112736 ; and references cited therein
• 9 Trabocchi A, Scarpi D, Guarna A. Amino Acids 2008; 34: 1
• 10 Hanessian S, Auzzas L. Acc. Chem. Res. 2008; 41: 1241
• 11 Vagner J, Qu H, Hruby VJ. Curr. Opin. Chem. Biol. 2008; 12: 292
• 12 Janecka A, Kruszynski R. Curr. Med. Chem. 2005; 12: 471
• 13 Komarov IV, Grigorenko AO, Turov AV, Khilya VP. Russ. Chem. Rev. 2004; 73: 785
• 14 Hanessian S, McNaughton-Smith G, Lombart H.-G, Lubell WD. Tetrahedron 1997; 53: 12789
• 15 Gibson SE, Guillo N, Tozer MJ. Tetrahedron 1999; 55: 585
• 16 Levandovskiy IA, Sharapa DI, Shamota TV, Rodionov VN, Shubina TE. Future Med. Chem. 2011; 3: 223
• 17 Allan RD, Johnston GA. R, Twitchin B. Aust. J. Chem. 1979; 32: 2517
• 18 Segal M, Sims K, Smissman E. Br. J. Pharmac. 1975; 54: 181
• 19 Kobayashi T, Suemasa A, Igawa A, Ide S, Fukuda H, Abe H, Arisawa M, Minami M, Shuto S. ACS Med. Chem. Lett. 2014; 5: 889
• 20 Witiak DT, Patch RJ, Enna SJ, Fung YK. J. Med. Chem. 1986; 29: 1
• 21 Melnykov KP, Volochnyuk DM, Ryabukhin SV, Rusanov EB, Grygorenko OO. Amino Acids 2019; 51: 255
• 22 Awada H, Robin S, Guillot R, Yazbeck O, Naoufal D, Jaber N, Hachem A, Aitken DJ. Eur. J. Org. Chem. 2014; 7148
• 23 Aitken DJ, Drouin L, Goretta S, Guillot R, Ollivier J, Spiga M. Org. Biomol. Chem. 2011; 9: 7517
• 24 Bakshi RK, Dellureficio JP, Dobbelaar PH, Guo L, He S, Hong Q, Nargund RP, Ye Z. Patent WO2007047496A2, 2007
• 25 Jacobson KA, Jung Y.-H, Wen Z. Patent WO2022155037A1, 2022
• 26 Trost BM, Chan DM. T. J. Am. Chem. Soc. 1979; 101: 6429
• 27 Lautens M, Klute W, Tam W. Chem. Rev. 1996; 96: 49
• 28 Yamago S, Nakamura E. Org. React. 2002; 61: 1
• 29 Evans DA, Bartroli J, Shih TL. J. Am. Chem. Soc. 1981; 103: 2127
• 30 Cowden CJ, Paterson I. Org. React. 1997; 51: 1
• 31 Singh R, Vince R. Chem. Rev. 2012; 112: 4642
• 32 Wetzel A, Bergman J, Brandt P, Larhed M, Brånalt J. Org. Lett. 2017; 19: 1602
• 33 Kamlet AS, Préville C, Farley KA, Piotrowski DW. Angew. Chem. Int. Ed. 2013; 52: 10607
• 34 Woll MG, Lai JR, Guzei IA, Taylor SJ. C, Smith ME. B, Gellman SH. J. Am. Chem. Soc. 2001; 123: 11077